Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoproteins | 21 | 2023 | 316 | 3.720 |
Why?
|
Lipoproteins, HDL | 19 | 2016 | 638 | 3.120 |
Why?
|
Kidney Diseases | 18 | 2022 | 2147 | 3.030 |
Why?
|
Glomerulosclerosis, Focal Segmental | 13 | 2023 | 359 | 2.190 |
Why?
|
Renal Insufficiency, Chronic | 14 | 2022 | 2208 | 2.100 |
Why?
|
Apyrase | 6 | 2009 | 364 | 1.000 |
Why?
|
Kidney Failure, Chronic | 8 | 2020 | 2538 | 0.930 |
Why?
|
Trypanosomiasis, African | 5 | 2017 | 28 | 0.930 |
Why?
|
Adenosine Deaminase | 1 | 2022 | 241 | 0.750 |
Why?
|
Interferon Type I | 1 | 2022 | 542 | 0.660 |
Why?
|
Saccharum | 1 | 2018 | 17 | 0.650 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2019 | 154 | 0.640 |
Why?
|
Genetic Predisposition to Disease | 22 | 2023 | 17449 | 0.630 |
Why?
|
Renal Insufficiency | 2 | 2016 | 804 | 0.630 |
Why?
|
AIDS-Associated Nephropathy | 5 | 2021 | 35 | 0.620 |
Why?
|
Hyperuricemia | 2 | 2018 | 211 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2018 | 15525 | 0.590 |
Why?
|
Tattooing | 1 | 2016 | 58 | 0.550 |
Why?
|
Antigens, CD | 6 | 2009 | 4026 | 0.540 |
Why?
|
Glomerulonephritis | 1 | 2018 | 372 | 0.530 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2015 | 85 | 0.500 |
Why?
|
Cosmetic Techniques | 1 | 2016 | 135 | 0.490 |
Why?
|
Diabetic Nephropathies | 3 | 2020 | 985 | 0.490 |
Why?
|
Immunity, Innate | 3 | 2017 | 2958 | 0.480 |
Why?
|
Kidney | 8 | 2022 | 7183 | 0.480 |
Why?
|
Lasers, Solid-State | 1 | 2016 | 169 | 0.480 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2013 | 6 | 0.480 |
Why?
|
Genetic Variation | 11 | 2020 | 6546 | 0.480 |
Why?
|
Evolution, Molecular | 2 | 2020 | 1939 | 0.420 |
Why?
|
Rural Population | 7 | 2011 | 2210 | 0.420 |
Why?
|
Glaucoma, Angle-Closure | 5 | 2012 | 189 | 0.420 |
Why?
|
Glaucoma, Open-Angle | 5 | 2012 | 711 | 0.390 |
Why?
|
Refractive Errors | 2 | 2009 | 142 | 0.390 |
Why?
|
Podocytes | 4 | 2022 | 396 | 0.390 |
Why?
|
Amblyopia | 2 | 2010 | 143 | 0.380 |
Why?
|
Genotype | 12 | 2023 | 12956 | 0.360 |
Why?
|
Occupational Diseases | 1 | 2018 | 1472 | 0.360 |
Why?
|
Biological Evolution | 2 | 2014 | 1076 | 0.340 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1971 | 0.340 |
Why?
|
Sequence Deletion | 3 | 2010 | 1526 | 0.330 |
Why?
|
Africa | 4 | 2020 | 673 | 0.320 |
Why?
|
Hypertension | 5 | 2020 | 8480 | 0.320 |
Why?
|
Glucuronidase | 1 | 2009 | 207 | 0.320 |
Why?
|
Gene Frequency | 9 | 2016 | 3588 | 0.310 |
Why?
|
Central America | 2 | 2018 | 68 | 0.310 |
Why?
|
Kidney Glomerulus | 4 | 2021 | 697 | 0.300 |
Why?
|
Interferons | 2 | 2022 | 706 | 0.290 |
Why?
|
Humans | 89 | 2023 | 744220 | 0.280 |
Why?
|
Strabismus | 2 | 2010 | 287 | 0.280 |
Why?
|
HEK293 Cells | 7 | 2023 | 4201 | 0.280 |
Why?
|
Proteinuria | 2 | 2023 | 657 | 0.260 |
Why?
|
Risk Factors | 31 | 2023 | 72280 | 0.250 |
Why?
|
Glomerular Filtration Rate | 3 | 2022 | 2170 | 0.240 |
Why?
|
Haplotypes | 4 | 2019 | 2781 | 0.240 |
Why?
|
Renal Dialysis | 2 | 2011 | 1787 | 0.230 |
Why?
|
Homeostasis | 1 | 2015 | 3339 | 0.230 |
Why?
|
Evoked Potentials | 1 | 2009 | 1057 | 0.230 |
Why?
|
Prevalence | 16 | 2018 | 15226 | 0.230 |
Why?
|
Mental Recall | 1 | 2009 | 1205 | 0.230 |
Why?
|
Creatinine | 4 | 2023 | 1919 | 0.220 |
Why?
|
Nicaragua | 3 | 2019 | 27 | 0.220 |
Why?
|
Age Distribution | 9 | 2011 | 2903 | 0.210 |
Why?
|
Cross-Sectional Studies | 21 | 2020 | 25043 | 0.210 |
Why?
|
Alleles | 7 | 2020 | 6938 | 0.210 |
Why?
|
Blood Glucose | 4 | 2015 | 6259 | 0.210 |
Why?
|
Inosine | 1 | 2022 | 133 | 0.210 |
Why?
|
Molecular Motor Proteins | 4 | 2015 | 107 | 0.210 |
Why?
|
Photography | 4 | 2012 | 520 | 0.200 |
Why?
|
Adenosine | 2 | 2022 | 825 | 0.200 |
Why?
|
Maternal Deprivation | 2 | 2012 | 48 | 0.200 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 820 | 0.200 |
Why?
|
Trabecular Meshwork | 2 | 2012 | 99 | 0.200 |
Why?
|
Crohn Disease | 2 | 2011 | 2303 | 0.200 |
Why?
|
RNA Editing | 1 | 2022 | 148 | 0.200 |
Why?
|
Sex Distribution | 7 | 2010 | 2297 | 0.200 |
Why?
|
Colitis | 1 | 2009 | 1170 | 0.200 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 290 | 0.190 |
Why?
|
Animals | 26 | 2023 | 168788 | 0.190 |
Why?
|
Insulin Resistance | 2 | 2012 | 3863 | 0.190 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2007 | 1121 | 0.190 |
Why?
|
3' Untranslated Regions | 1 | 2022 | 513 | 0.190 |
Why?
|
Myosin Heavy Chains | 4 | 2015 | 414 | 0.190 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4328 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2015 | 11732 | 0.180 |
Why?
|
Balkan Nephropathy | 1 | 2019 | 1 | 0.170 |
Why?
|
Male | 47 | 2022 | 350027 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 154 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2018 | 4477 | 0.170 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1912 | 0.170 |
Why?
|
Cell Respiration | 1 | 2019 | 200 | 0.170 |
Why?
|
Mice | 17 | 2023 | 81178 | 0.170 |
Why?
|
Mining | 1 | 2019 | 88 | 0.170 |
Why?
|
Trypanosoma brucei rhodesiense | 3 | 2016 | 12 | 0.160 |
Why?
|
Vitamin D | 1 | 2012 | 3222 | 0.160 |
Why?
|
Adult | 32 | 2019 | 214035 | 0.160 |
Why?
|
Uromodulin | 1 | 2018 | 46 | 0.160 |
Why?
|
Gonioscopy | 3 | 2012 | 157 | 0.160 |
Why?
|
Receptors, OX40 | 1 | 2017 | 43 | 0.150 |
Why?
|
Genetic Association Studies | 4 | 2019 | 2702 | 0.150 |
Why?
|
Baltimore | 4 | 2011 | 231 | 0.150 |
Why?
|
Female | 45 | 2022 | 380197 | 0.150 |
Why?
|
Macular Degeneration | 2 | 2004 | 981 | 0.150 |
Why?
|
Proteoglycans | 1 | 2020 | 835 | 0.150 |
Why?
|
Serum Albumin | 2 | 2013 | 676 | 0.150 |
Why?
|
China | 7 | 2011 | 2247 | 0.140 |
Why?
|
Intraocular Pressure | 6 | 2012 | 1274 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2016 | 2563 | 0.140 |
Why?
|
Middle Aged | 32 | 2020 | 213367 | 0.140 |
Why?
|
Cell Death | 2 | 2019 | 1708 | 0.140 |
Why?
|
Aged | 29 | 2019 | 163253 | 0.140 |
Why?
|
Ubiquitins | 1 | 2018 | 384 | 0.140 |
Why?
|
Visually Impaired Persons | 2 | 2009 | 81 | 0.130 |
Why?
|
RNA, Messenger | 3 | 2022 | 13036 | 0.130 |
Why?
|
HIV Infections | 1 | 2022 | 16718 | 0.130 |
Why?
|
Optic Nerve Diseases | 2 | 2012 | 328 | 0.130 |
Why?
|
Color | 1 | 2016 | 307 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 602 | 0.130 |
Why?
|
Hyperopia | 2 | 2011 | 44 | 0.130 |
Why?
|
Anterior Chamber | 2 | 2012 | 197 | 0.120 |
Why?
|
Ion Transport | 1 | 2015 | 320 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2009 | 2425 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2019 | 21752 | 0.120 |
Why?
|
Mice, Knockout | 5 | 2018 | 14556 | 0.120 |
Why?
|
Visual Acuity | 6 | 2010 | 2530 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2019 | 971 | 0.120 |
Why?
|
Pedigree | 2 | 2020 | 4648 | 0.120 |
Why?
|
Astigmatism | 2 | 2011 | 69 | 0.120 |
Why?
|
Toll-Like Receptor 3 | 1 | 2014 | 91 | 0.120 |
Why?
|
Interferon-gamma | 1 | 2022 | 3203 | 0.120 |
Why?
|
Gene Duplication | 1 | 2015 | 330 | 0.120 |
Why?
|
Protein Transport | 1 | 2019 | 1989 | 0.120 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2012 | 245 | 0.110 |
Why?
|
Proteomics | 2 | 2020 | 3637 | 0.110 |
Why?
|
Meta-Analysis as Topic | 1 | 2018 | 1344 | 0.110 |
Why?
|
Aged, 80 and over | 19 | 2012 | 57768 | 0.110 |
Why?
|
Antiporters | 2 | 2004 | 277 | 0.110 |
Why?
|
Environment | 1 | 2019 | 1124 | 0.110 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2012 | 90 | 0.110 |
Why?
|
Immunotherapy | 2 | 2018 | 4440 | 0.110 |
Why?
|
Phenotype | 5 | 2020 | 16365 | 0.100 |
Why?
|
Lupus Nephritis | 1 | 2015 | 310 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2019 | 6612 | 0.100 |
Why?
|
Myopia | 2 | 2011 | 254 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 933 | 0.100 |
Why?
|
Occupational Health | 1 | 2018 | 809 | 0.100 |
Why?
|
Visual Fields | 5 | 2012 | 1049 | 0.100 |
Why?
|
Haploidy | 1 | 2011 | 136 | 0.100 |
Why?
|
Anterior Eye Segment | 1 | 2012 | 152 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1336 | 0.100 |
Why?
|
Aging | 2 | 2009 | 8661 | 0.100 |
Why?
|
Linkage Disequilibrium | 3 | 2013 | 1997 | 0.100 |
Why?
|
Exfoliation Syndrome | 1 | 2012 | 111 | 0.100 |
Why?
|
Autophagy | 1 | 2019 | 1300 | 0.100 |
Why?
|
Diabetic Retinopathy | 2 | 2011 | 1210 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1284 | 0.090 |
Why?
|
RNA Interference | 1 | 2019 | 2890 | 0.090 |
Why?
|
Iris | 1 | 2011 | 239 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3505 | 0.090 |
Why?
|
Blindness | 2 | 2004 | 617 | 0.090 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1660 | 0.090 |
Why?
|
Disease Progression | 5 | 2018 | 13280 | 0.080 |
Why?
|
Epiretinal Membrane | 1 | 2008 | 68 | 0.080 |
Why?
|
Macaca mulatta | 2 | 2012 | 2378 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6535 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5953 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2012 | 748 | 0.080 |
Why?
|
Serotonin | 1 | 2012 | 1023 | 0.070 |
Why?
|
Tomography, Optical Coherence | 4 | 2012 | 2657 | 0.070 |
Why?
|
Liver | 2 | 2016 | 7472 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2012 | 6367 | 0.070 |
Why?
|
Glomerular Mesangium | 1 | 2007 | 108 | 0.070 |
Why?
|
Time Factors | 6 | 2017 | 40063 | 0.070 |
Why?
|
Streptozocin | 1 | 2007 | 193 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2022 | 9735 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1940 | 0.070 |
Why?
|
Tonometry, Ocular | 3 | 2012 | 237 | 0.070 |
Why?
|
Singapore | 3 | 2012 | 295 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2603 | 0.070 |
Why?
|
5'-Nucleotidase | 1 | 2007 | 160 | 0.070 |
Why?
|
Fasting | 1 | 2012 | 1591 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 21824 | 0.070 |
Why?
|
Functional Laterality | 2 | 2010 | 2290 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13817 | 0.070 |
Why?
|
Renin | 1 | 2008 | 642 | 0.070 |
Why?
|
Kidney Tubules | 1 | 2008 | 488 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2016 | 2118 | 0.070 |
Why?
|
Ethanol | 1 | 2012 | 1342 | 0.070 |
Why?
|
Gene Products, tat | 2 | 1995 | 120 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8321 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4251 | 0.060 |
Why?
|
Genome, Human | 3 | 2015 | 4420 | 0.060 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2004 | 103 | 0.060 |
Why?
|
Young Adult | 8 | 2020 | 56436 | 0.060 |
Why?
|
Mutation | 4 | 2019 | 29784 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2017 | 18027 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2732 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2010 | 881 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2008 | 0.060 |
Why?
|
Pseudophakia | 1 | 2004 | 62 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2004 | 54 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2015 | 1797 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5722 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1365 | 0.060 |
Why?
|
Cornea | 1 | 2012 | 1524 | 0.060 |
Why?
|
Age of Onset | 3 | 2019 | 3270 | 0.060 |
Why?
|
Retinal Diseases | 1 | 2009 | 683 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2011 | 1881 | 0.060 |
Why?
|
Eye Diseases | 1 | 2009 | 668 | 0.060 |
Why?
|
Hypertonic Solutions | 1 | 2003 | 93 | 0.060 |
Why?
|
Egtazic Acid | 1 | 2003 | 173 | 0.060 |
Why?
|
Human Genome Project | 2 | 2015 | 192 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 18116 | 0.060 |
Why?
|
Reaction Time | 1 | 2009 | 2102 | 0.060 |
Why?
|
Body Composition | 1 | 2012 | 2400 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1343 | 0.050 |
Why?
|
Diacylglycerol O-Acyltransferase | 1 | 2022 | 22 | 0.050 |
Why?
|
Anion Transport Proteins | 1 | 2003 | 142 | 0.050 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2003 | 205 | 0.050 |
Why?
|
Models, Genetic | 1 | 2012 | 3494 | 0.050 |
Why?
|
United States | 9 | 2015 | 69867 | 0.050 |
Why?
|
Cohort Studies | 3 | 2014 | 40559 | 0.050 |
Why?
|
Vision, Low | 1 | 2004 | 168 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 85759 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4665 | 0.050 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2021 | 126 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 503 | 0.050 |
Why?
|
Atherosclerosis | 2 | 2015 | 3444 | 0.050 |
Why?
|
Los Angeles | 2 | 2011 | 238 | 0.050 |
Why?
|
Risk Assessment | 3 | 2018 | 23337 | 0.050 |
Why?
|
Cataract | 2 | 2004 | 834 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2020 | 28 | 0.050 |
Why?
|
Urban Population | 1 | 2009 | 2021 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6172 | 0.050 |
Why?
|
Retinoscopy | 2 | 2011 | 27 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 537 | 0.050 |
Why?
|
Vision Disorders | 1 | 2008 | 1059 | 0.050 |
Why?
|
Child, Preschool | 6 | 2019 | 40992 | 0.050 |
Why?
|
Hantavirus Infections | 1 | 2019 | 1 | 0.050 |
Why?
|
Leptospira | 1 | 2019 | 11 | 0.040 |
Why?
|
Insulin | 2 | 2012 | 6583 | 0.040 |
Why?
|
Sri Lanka | 1 | 2019 | 90 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4419 | 0.040 |
Why?
|
Leptospirosis | 1 | 2019 | 29 | 0.040 |
Why?
|
Child | 8 | 2020 | 77679 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 3966 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 1028 | 0.040 |
Why?
|
Heterozygote | 2 | 2015 | 2805 | 0.040 |
Why?
|
Biometry | 2 | 2012 | 558 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29050 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 683 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1539 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2011 | 5755 | 0.040 |
Why?
|
Body Mass Index | 2 | 2012 | 12718 | 0.040 |
Why?
|
Ion Channels | 1 | 2022 | 1056 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2525 | 0.040 |
Why?
|
Risk | 3 | 2015 | 9685 | 0.040 |
Why?
|
Blood Pressure | 2 | 2010 | 8551 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2018 | 964 | 0.040 |
Why?
|
Anxiety | 1 | 2011 | 4297 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2019 | 981 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2011 | 4245 | 0.030 |
Why?
|
Cytokine Receptor gp130 | 1 | 2015 | 66 | 0.030 |
Why?
|
Infant | 4 | 2011 | 35129 | 0.030 |
Why?
|
Endosomes | 1 | 2019 | 520 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12075 | 0.030 |
Why?
|
Incidence | 4 | 2015 | 20945 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2016 | 354 | 0.030 |
Why?
|
Signal Transduction | 3 | 2014 | 23404 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
Hypertension, Renal | 1 | 2015 | 177 | 0.030 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1995 | 113 | 0.030 |
Why?
|
Optic Disk | 2 | 2012 | 401 | 0.030 |
Why?
|
Mandrillus | 1 | 2014 | 5 | 0.030 |
Why?
|
Nephritis | 1 | 2015 | 158 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2085 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6150 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15999 | 0.030 |
Why?
|
Brain Mapping | 1 | 2009 | 6671 | 0.030 |
Why?
|
Brain | 2 | 2012 | 26413 | 0.030 |
Why?
|
Lysosomes | 1 | 2019 | 893 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2018 | 7879 | 0.030 |
Why?
|
Cell Size | 1 | 2015 | 643 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2007 | 2988 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2016 | 414 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 507 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12264 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 5987 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5102 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 1144 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3701 | 0.030 |
Why?
|
Papio | 1 | 2014 | 656 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1880 | 0.030 |
Why?
|
Chromatography | 1 | 2012 | 206 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2015 | 643 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2018 | 77426 | 0.030 |
Why?
|
Geography | 1 | 2014 | 670 | 0.030 |
Why?
|
Ciliary Body | 1 | 2012 | 173 | 0.030 |
Why?
|
Xenopus | 2 | 2004 | 712 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1039 | 0.030 |
Why?
|
Albuminuria | 1 | 2015 | 683 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2839 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 874 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3294 | 0.020 |
Why?
|
Phosphorylation | 2 | 2015 | 8437 | 0.020 |
Why?
|
Anisometropia | 1 | 2010 | 13 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1786 | 0.020 |
Why?
|
Trabeculectomy | 1 | 2012 | 162 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1792 | 0.020 |
Why?
|
Prospective Studies | 4 | 2019 | 53280 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2014 | 3591 | 0.020 |
Why?
|
Transfection | 2 | 2015 | 5892 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4188 | 0.020 |
Why?
|
Blood Pressure Monitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2011 | 270 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 462 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2016 | 4321 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2010 | 109 | 0.020 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2010 | 108 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 279 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 977 | 0.020 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2010 | 109 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1736 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12742 | 0.020 |
Why?
|
Time | 1 | 2011 | 541 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15161 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5757 | 0.020 |
Why?
|
Lysine | 1 | 2014 | 1008 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1838 | 0.020 |
Why?
|
Mydriatics | 1 | 2009 | 68 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2004 | 2557 | 0.020 |
Why?
|
Odds Ratio | 2 | 2011 | 9849 | 0.020 |
Why?
|
Oocytes | 2 | 2004 | 1187 | 0.020 |
Why?
|
Optic Nerve | 1 | 2012 | 556 | 0.020 |
Why?
|
Body Constitution | 1 | 2009 | 278 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7326 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12355 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1525 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 454 | 0.020 |
Why?
|
Vision Tests | 1 | 2009 | 167 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16687 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2017 | 2540 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
Pupil | 1 | 2009 | 149 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1995 | 1836 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 4012 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1586 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 266 | 0.020 |
Why?
|
Refraction, Ocular | 1 | 2009 | 182 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2010 | 383 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1990 | 0.020 |
Why?
|
HIV-1 | 2 | 1995 | 6938 | 0.020 |
Why?
|
Wound Healing | 1 | 2018 | 2785 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2015 | 1018 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18367 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2004 | 2050 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14726 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3772 | 0.020 |
Why?
|
Amino Acids | 1 | 2013 | 1734 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2004 | 3846 | 0.020 |
Why?
|
Logistic Models | 2 | 2012 | 13409 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 452 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2593 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 563 | 0.020 |
Why?
|
Genes, tat | 2 | 1995 | 15 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2575 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1359 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 914 | 0.020 |
Why?
|
RNA, Complementary | 1 | 2004 | 45 | 0.020 |
Why?
|
Cause of Death | 1 | 2015 | 3584 | 0.020 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 2 | 1995 | 127 | 0.020 |
Why?
|
Hyperinsulinism | 1 | 2008 | 415 | 0.020 |
Why?
|
Chlorine | 1 | 2004 | 50 | 0.020 |
Why?
|
Anions | 1 | 2004 | 133 | 0.020 |
Why?
|
Macular Edema | 1 | 2009 | 359 | 0.020 |
Why?
|
Sodium Bicarbonate | 1 | 2004 | 62 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 2004 | 305 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1995 | 2948 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
Oxalates | 1 | 2004 | 105 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19907 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4742 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4803 | 0.010 |
Why?
|
Sulfates | 1 | 2004 | 390 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 839 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12781 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3598 | 0.010 |
Why?
|
Codon | 1 | 2004 | 611 | 0.010 |
Why?
|
Asia | 1 | 2004 | 610 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2422 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 689 | 0.010 |
Why?
|
Adipose Tissue, Brown | 1 | 2008 | 754 | 0.010 |
Why?
|
Electrodes | 1 | 2004 | 619 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2505 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7799 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 2025 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1869 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1210 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1686 | 0.010 |
Why?
|
Chelating Agents | 1 | 2003 | 380 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1682 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1724 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1169 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 1471 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9230 | 0.010 |
Why?
|
Biological Transport | 1 | 2004 | 2120 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2008 | 2440 | 0.010 |
Why?
|
Apoptosis | 1 | 1995 | 9728 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1971 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2916 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 63119 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10182 | 0.010 |
Why?
|
Causality | 1 | 2004 | 1275 | 0.010 |
Why?
|
Europe | 1 | 2004 | 3339 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1995 | 6313 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3133 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2008 | 2895 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11493 | 0.010 |
Why?
|
Imidazoles | 1 | 2003 | 1206 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11368 | 0.010 |
Why?
|
Smoking | 1 | 2012 | 8986 | 0.010 |
Why?
|
HIV Long Terminal Repeat | 1 | 1995 | 88 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11007 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1995 | 191 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11728 | 0.010 |
Why?
|
Glaucoma | 1 | 2004 | 1159 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10396 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7148 | 0.010 |
Why?
|
Base Sequence | 2 | 1995 | 12801 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 4935 | 0.010 |
Why?
|
Genes, p53 | 1 | 1995 | 755 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4407 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19227 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1995 | 671 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 13885 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1782 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 13990 | 0.000 |
Why?
|
Down-Regulation | 1 | 1995 | 3001 | 0.000 |
Why?
|
Quality of Life | 1 | 2009 | 12805 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9335 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5867 | 0.000 |
Why?
|